Over 500 Strong, and Just Getting Started

This weekend, more than 500 of you raised your hand and said,

“I want more than just headlines. I want to understand what is really going on.”

That is exactly what we are building here.

This is not just a newsletter. It is a space for people asking better questions.

For the ones who want to know what the lobbyists are whispering, what pharma is quietly planning, and why patients keep getting left behind.

You did not show up for fluff.

You showed up for facts, clarity, and maybe even a little fire.

So thank you. Every single one of you.

And if you are new here, welcome. You can expect:

• Smart, fast, and fearless updates on obesity and diabetes care

• Deep dives into policy, pricing, and pharma strategy

• News with a side of advocacy that never forgets the patient

Want to go deeper?

The majority of my inside analysis will live on the paid side of this publication. That includes what is coming later this week.

If you have found value in what I have shared so far,

I would love to have you step into that next level with us.

(It helps fund the tireless work. It helps drive the mission. It helps keep the pressure on.)

And either way, I am glad you are here.